PROTEASOME PEPTIDASE ACTIVITIES PARALLEL HISTOMORPHOLOGICAL AND FUNCTIONAL CONSEQUENCES OF ISCHEMIA-REPERFUSION INJURY IN THE LUNG

REFERENCES

• Baumeister W, Walz J, Zuhl F, Seemuller E. The proteasome: paradigm of a self-compartmentalizing protease. Cell 1998; 92: 367–380
   PubMed Web of Science ®Google Scholar
• Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67: 425–479
   PubMed Web of Science ®Google Scholar
• Orlowski M. The multicatalytic proteinase complex, a major extralysosomal proteolytic system. Biochemistry 1990; 29: 10289–10297
   PubMed Web of Science ®Google Scholar
• Groll M, Huber R. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach. Biochim Biophys Acta 2004; 1695: 33–44
   PubMed Web of Science ®Google Scholar
• Rivett A J. Proteasomes: multicatalytic proteinase complexes. Biochem J 1993; 291: 1–10, (Pt 1)
   PubMed Web of Science ®Google Scholar
• Eytan E, Armon T, Heller H, Beck S, Hershko A. Ubiquitin C-terminal hydrolase activity associated with the 26 S protease complex. J Biol Chem 1993; 268: 4668–4674
   PubMed Web of Science ®Google Scholar
• Orlowski M, Wilk S. Ubiquitin-independent proteolytic functions of the proteasome. Arch Biochem Biophys 2003; 415: 1–5
   PubMed Web of Science ®Google Scholar
• Kukan M. Emerging roles of proteasomes in ischemia-reperfusion injury of organs. J Physiol Pharmacol 2004; 55: 3–15
   PubMed Web of Science ®Google Scholar
• Campbell B, Adams J, Shin Y K, Lefer A M. Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart. J Mol Cell Cardiol 1999; 31: 467–476
   PubMed Web of Science ®Google Scholar
• Stansfield W E, Moss N C, Willis M S, Tang R, Selzman C H. Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury. Ann Thorac Surg 2007; 84: 120–125
   PubMed Web of Science ®Google Scholar
• Phillips J B, Williams A J, Adams J, Elliott P J, Tortella F C. Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. Stroke 2000; 31: 1686–1693
   PubMed Web of Science ®Google Scholar
• Alexandrova A, Petrov L, Georgieva A, Kessiova M, Tzvetanova E, Kirkova M, Kukan M. Effect of MG132 on proteasome activity and prooxidant/antioxidant status of rat liver subjected to ischemia/reperfusion injury. Hepatol Res 2008; 38: 393–401
   PubMed Web of Science ®Google Scholar
• Takaoka M, Itoh M, Kohyama S, Shibata A, Ohkita M, Matsumura Y. Proteasome inhibition attenuates renal endothelin-1 production and the development of ischemic acute renal failure in rats. J Cardiovasc Pharmacol 2000; 36: S225–227
   PubMed Web of Science ®Google Scholar
• Wang J, Jiang S, Kwong J M, Sanchez R N, Sadun A A, Lam T T. Nuclear factor-kappaB p65 and upregulation of interleukin-6 in retinal ischemia/reperfusion injury in rats. Brain Res 2006; 1081: 211–218
   PubMed Web of Science ®Google Scholar
• Park J W, Qi W N, Cai Y, Urbaniak J R, Chen L E. Proteasome inhibitor attenuates skeletal muscle reperfusion injury by blocking the pathway of nuclear factor-kappaB activation. Plast Reconstr Surg 2007; 120: 1808–1818
   PubMed Web of Science ®Google Scholar
• Bulteau A L, Lundberg K C, Humphries K M, Sadek H A, Szweda P A, Friguet B, Szweda L I. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 2001; 276: 30057–30063
   PubMed Web of Science ®Google Scholar
• Powell S R, Wang P, Katzeff H, Shringarpure R, Teoh C, Khaliulin I, Das D K, Davies K J, Schwalb H. Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid Redox Signal 2005; 7: 538–546
   PubMed Web of Science ®Google Scholar
• Majetschak M, Patel M B, Sorell L T, Liotta C, Li S, Pham S M. Cardiac proteasome dysfunction during cold ischemic storage and reperfusion in a murine heart transplantation model. Biochem Biophys Res Commun 2008; 365: 882–888
   PubMed Web of Science ®Google Scholar
• Keller J N, Huang F F, Zhu H, Yu J, Ho Y S, Kindy T S. Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J Cereb Blood Flow Metab 2000; 20: 1467–1473
   PubMed Web of Science ®Google Scholar
• Ovechkin A V, Lominadze D, Sedoris K C, Robinson T W, Tyagi S C, Roberts A M. Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions. Arch Physiol Biochem 2007; 113: 1–12
   PubMedGoogle Scholar
• Eppinger M J, Deeb G M, Bolling S F, Ward P A. Mediators of ischemia-reperfusion injury of rat lung. Am J Pathol 1997; 150: 1773–1784
   PubMed Web of Science ®Google Scholar
• Garcia-Covarrubias L, Manning E W, 3rd, Sorell L T, Pham S M, Majetschak M. Ubiquitin enhances the Th2 cytokine response and attenuates ischemia-reperfusion injury in the lung. Crit Care Med 2008; 36: 979–982
   PubMed Web of Science ®Google Scholar
• Furue S, Kuwabara K, Mikawa K, Nishina K, Shiga M, Maekawa N, Ueno M, Chikazawa Y, Ono T, Hori Y, Matsukawa A, Yoshinaga M, Obara H. Crucial role of group IIA phospholipase A(2) in oleic acid-induced acute lung injury in rabbits. Am J Respir Crit Care Med 1999; 160: 1292–1302
   PubMed Web of Science ®Google Scholar
• Kandilci H B, Gumusel B, Topaloglu E, Ucar G, Korkusuz P, Ugur Y, Asan E, Demiryurek A T. Effects of ischemic preconditioning on rat lung: role of nitric oxide. Exp Lung Res 2006; 32: 287–303
   PubMed Web of Science ®Google Scholar
• Okada Y, Marchevsky A M, Zuo X J, Pass J A, Kass R M, Matloff J M, Jordan S C. Accumulation of platelets in rat syngeneic lung transplants: a potential factor responsible for preservation-reperfusion injury. Transplantation 1997; 64: 801–806
   PubMed Web of Science ®Google Scholar
• Patel M B, Majetschak M. Distribution and interrelationship of ubiquitin proteasome pathway component activities and ubiquitin pools in various porcine tissues. Physiol Res 2007; 56: 341–350
   PubMed Web of Science ®Google Scholar
• Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Meng L, Mohan R, Kwok B H, Elofsson M, Sin N, Crews C M. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A 1999; 96: 10403–10408
   PubMed Web of Science ®Google Scholar
• Gunther A, Balser M, Schmidt R, Markart P, Olk A, Borgermann J, Splittgerber F H, Seeger W, Friedrich I. Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration. J Thorac Cardiovasc Surg 2004; 127: 344–354
   PubMed Web of Science ®Google Scholar
• Markart P, Schmidt R, Ruppert C, Hores C, Silber R E, Borgermann J, Gunther A, Friedrich I. Ischemic and endotoxin pre-conditioning reduce lung reperfusion injury-induced surfactant alterations. J Heart Lung Transplant 2005; 24: 1680–1689
   PubMed Web of Science ®Google Scholar
• Das A, Boggaram V. Proteasome dysfunction inhibits surfactant protein gene expression in lung epithelial cells: mechanism of inhibition of SP-B gene expression. Am J Physiol Lung Cell Mol Physiol 2007; 292: L74–L84
   PubMed Web of Science ®Google Scholar
• Sixt S U, Beiderlinden M, Jennissen H P, Peters J. Extracellular proteasome in the human alveolar space: a new housekeeping enzyme?. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1280–L1288
   PubMed Web of Science ®Google Scholar
• Majetschak M, Sorell L T, Patricelli T, Seitz D H, Knoferl M W. Detection and possible role of proteasomes in the bronchoalveolar space of the injured lung. Physiol Res 2008, Jul 18. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Patel M B, Earle S A, Majetschak M. Dynamics of tissue ubiquitin pools and ubiquitin-proteasome pathway component activities during the systemic response to traumatic shock. Physiol Res 2007; 56: 547–557
   PubMed Web of Science ®Google Scholar
• Farout L, Mary J, Vinh J, Szweda L I, Friguet B. Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch Biochem Biophys 2006; 453: 135–142
   PubMed Web of Science ®Google Scholar